Enzyme-linked immunosorbent assay (ELISA) created in the 1970s, is widely used due to its high specificity, sensitivity, and stability which nowadays commonly used in both research and clinical diagnostics. Recently, with the COVID-19 pandemic, ELISA is employed as one of detection kits, and become crucial part for both diagnostics and population surveillance purposes.
The demand of custom ELISA kits that are inexpensive and reliable are growing rapidly with scientists’ increasing needs of kits that are able to handling complex tasks. In Genscript, with suitable antibodies available, we can develop an acceptable ELISA in a few days. In practice, the stages of developing a particular ELISA for in-house use are Phase I: Prove of concept (POC). Phase II: Assay development. Phase III: Assay validation Phase. Phase IV: Assay manufacturing.
In this webinar, you will learn:
- Background of the ELISA kit.
- Various ELISA kit and Application.
- Key parameter optimization for ELISA kit development and trouble shooting.
- Case study for COVID-19 ELISA kit development.
Pei Liu graduated from Nanjing University with a PhD in Pharmacy. She joined the GenScript in 2019 and served as a SS in antibody department. Her work is mainly engaged in antibody development and the establishment of single B cell platform. In addition, she worked with various cases and have accumulated a wealth of experience on the development of ELISA kit.